2026 U.S. price guide
How Much Do GLP-1 Medications Cost in 2026?
Wegovy, Zepbound, Ozempic, Mounjaro and other GLP-1 medications can cost from roughly $25 to more than $1,300 per month in the United States. Your actual price depends on the medicine, indication, insurance, dose and eligibility for savings or direct-pay programs.
The short answer
List price is no longer the whole story.
A medicine with a list price above $1,000 may cost an eligible self-pay patient a few hundred dollars through its manufacturer, or an eligible commercially insured patient as little as $25. Compare the total monthly cost—including visits, labs, membership fees and shipping—not just the advertised starting price.
At a glance
GLP-1 Cost Comparison: 2026
These U.S. figures are a guide, not a price guarantee. Offers, formularies and eligibility rules change frequently.
| Medication | Ingredient | Primary use | Approx. list price | Potential cost |
|---|---|---|---|---|
| Wegovy | Semaglutide | Weight management | $1,349.02/package | $199 introductory; generally $349/month for common injectable doses |
| Zepbound | Tirzepatide | Weight management | Varies by presentation | $299–$449/month through qualifying LillyDirect vial offers |
| Ozempic | Semaglutide | Type 2 diabetes | $1,027.51/pen | As little as $25 with eligible commercial insurance; $199 introductory, then $349–$499 self-pay |
| Mounjaro | Tirzepatide | Type 2 diabetes | $1,112.16/28 days | As little as $25 with an eligible commercial insurance savings card; otherwise plan-dependent |
| Saxenda | Liraglutide | Weight management | $1,349.02/package | Coverage varies; final wholesaler shipments expected in January 2027 |
| Trulicity | Dulaglutide | Type 2 diabetes | Varies | As little as $25 for eligible commercially insured patients |
| Rybelsus | Semaglutide | Type 2 diabetes | Varies | Insurance and manufacturer-program dependent |
| Victoza / liraglutide | Liraglutide | Type 2 diabetes | Varies | Generic options may substantially reduce cost |
Four prices can exist for the same prescription
1
List price
The manufacturer's published price before coverage or discounts.
2
Insurance price
Your plan's negotiated price, deductible and copay for the exact drug and diagnosis.
3
Savings-card price
A manufacturer discount for some commercially insured patients, with eligibility rules and limits.
4
Direct self-pay price
A cash price offered through a manufacturer program, usually without using insurance.
How much does Wegovy cost in 2026?
Injectable Wegovy has a list price of $1,349.02 per package. Through NovoCare, eligible self-pay patients currently pay $349 per month for common injectable doses. New eligible patients may pay $199 for each of the first two fills of 0.25 mg or 0.5 mg through December 31, 2026. Eligible commercially insured patients may pay as little as $25, subject to program rules and savings limits. Check current Wegovy terms.
How much does Zepbound cost without insurance?
LillyDirect currently lists Zepbound single-dose vials at $299 per month for 2.5 mg, $399 for 5 mg and as low as $449 for 7.5–15 mg when refill conditions are met. Standard prices for higher doses may reach $499–$699 when offer conditions are not met. A telehealth service may add clinical or membership fees to this manufacturer price. Check current Zepbound terms.
Ozempic cost in 2026
Ozempic's list price is $1,027.51 per pen. Eligible new self-pay patients may currently pay $199 for each of their first two starter-dose fills, then $349 per month for 0.25, 0.5 or 1 mg and $499 for 2 mg. Eligible commercially insured patients may pay as little as $25 under capped program terms. Ozempic and Wegovy contain semaglutide, but have different approved uses and dosing; one is not simply a cheaper substitute for the other. Check current Ozempic terms.
Mounjaro and older GLP-1 medications
Mounjaro's list price is approximately $1,112.16 for a 28-day supply. Eligible commercially insured patients with coverage for Mounjaro may qualify for savings as low as $25, while people without coverage can pay far more. Trulicity and Rybelsus are diabetes medicines whose costs depend heavily on coverage and program eligibility. Generic liraglutide may cost less than branded Victoza. Saxenda is being discontinued, with final wholesaler shipments expected in January 2027.
With insurance
Ask about the exact drug and diagnosis
A plan may cover Ozempic for type 2 diabetes but exclude Wegovy for weight management. Another may require prior authorization. Ask whether your specific plan covers the exact medicine for your specific diagnosis, what criteria apply and what you will owe before and after your deductible.
Medicare
The 2026 GLP-1 Bridge
Beginning July 1, 2026, eligible Part D beneficiaries can obtain certain weight-management medicines for $50 per month through a temporary program running through December 31, 2027. It covers Wegovy, Zepbound KwikPen and Foundayo under detailed eligibility rules—not every GLP-1 or every Medicare enrollee. Read the Medicare fact sheet.
Are compounded GLP-1s cheaper?
They can be, but price is not the only consideration. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness and manufacturing quality in the same way as approved medicines. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide injection shortage resolved in February 2025; in 2026 it further clarified restrictions on making copies of commercially available drugs.
Compounding can still serve an individual clinical need, but “generic Ozempic” and “generic Zepbound” are misleading descriptions. Confirm the exact product, prescriber and dispensing pharmacy, and be cautious with sellers offering prices that appear too good to be true. Read the FDA update.
Before you pay
How to find the lowest legitimate price
- 1. Check coverage for the exact drug and indication. Ask about prior authorization, deductibles and preferred pharmacies.
- 2. Check the official manufacturer program. Confirm eligibility and the date an offer ends.
- 3. Compare direct self-pay options. A manufacturer's cash price may be far below list price.
- 4. Calculate the all-in monthly price. Add medication, appointments, labs, membership fees and shipping.
- 5. Verify what you will receive. Determine whether it is an FDA-approved brand or a compounded product.
- 6. Compare the annual total. A $300 monthly difference becomes $3,600 in a year.
The real cost of treatment
The prescription may not be the complete cost. Medical visits, laboratory testing, nutrition support, side-effect management, body-composition monitoring and long-term maintenance can all matter. The cheapest prescription is not automatically the lowest-cost care if it provides little medical supervision or no support for preserving muscle and nutrition.
Frequently asked questions
How much does a GLP-1 cost per month?
In the United States, the amount can range from about $25 with eligible commercial insurance savings to more than $1,300 at list price. Manufacturer self-pay programs for some branded weight-management medicines currently start around $299–$349 per month after introductory offers.
How much does Wegovy cost without insurance?
Eligible self-pay patients can currently pay $349 per month for common injectable doses through NovoCare. New eligible patients may pay $199 for each of their first two fills at certain starter doses through December 31, 2026.
How much does Zepbound cost without insurance?
Current LillyDirect vial pricing starts at $299 per month for 2.5 mg, $399 for 5 mg and as low as $449 for certain higher doses when refill conditions are met. Regular pricing can be higher.
Which GLP-1 is cheapest in 2026?
There is no single cheapest medication for everyone. Zepbound currently has a $299 manufacturer-direct starting-dose option, while eligible insured patients may pay as little as $25 for certain medicines. Coverage, diagnosis, dose and eligibility determine the real answer.
References and official price sources
- 1.NovoCare Pharmacy: Wegovy pricing and offer terms. View source
- 2.Novo Nordisk: Ozempic list price. View source
- 3.NovoCare Pharmacy: Ozempic self-pay pricing. View source
- 4.LillyDirect: Zepbound self-pay options. View source
- 5.Lilly: Mounjaro savings and resources. View source
- 6.Lilly: Trulicity savings and resources. View source
- 7.Medicare: GLP-1 Bridge fact sheet. View source
- 8.FDA: semaglutide shortage resolution. View source
- 9.FDA: clarification of GLP-1 compounding policies. View source
- 10.Novo Nordisk: Saxenda availability update. View source
